title: [Mutation in the beta3-adrenergic receptor gene (Trp64Arg) does not influence insulin resistence, energy metabolism, fat distribution and lipid spectrum in young people. Pilot study].
abstract: A missence mutation Trp64Arg in the beta3-adrenergic receptor gene is associated with obesity, insulin resistance, a lower metabolic rate and the earlier onset of NIDDM but the published results are controversial. We investigated the effect of this mutation on insulin resistance (euglycemic hyperinsulinemic clamp), on fat mass and fat distribution (anthropometry, bioimpedance, CT) and resting metabolic rate (indirect calorimetry), lipid spectrum and other metabolic disturbances in Czech juveniles recruited from juvenile hypertensives (H, n = 68) and controls (C, n = 81). The frequency of this mutation (determined by digestion of 210 bp PCR product with MvaI) was double in H than in C (14.7%, vs. 7.4%) and the carriers of Arg64 allele had sig. higher fasting glucose (H: p = 0.002. C: p = 0.025). Four Trp64/Arg64 and six Trp64/Trp64 men (age 23 +/- 4.2, vs. 22.5 +/- 1.9 y, BMI 26 +/- 5.5, vs. 22.9 +/- 5.1 kg/m2) took part in a detailed pilot study. But no signif. differences (Horn's method) in fasting glucose (4.6 +/- 0.6, vs. 4.9 +/- 0.4 mmol/l), in parameters of insulin resistance (M-value150-180 min. 9.1 +/- 1.1, vs. 8.9 +/- 1.5 mg glucose/kg.min(-1)), resting metabolic rate/lean body mass (RMR/kg LBM: 78.6 +/- 4.6, vs. 85.6 +/- 23.2 kJ/kg), lipid spectrum and other screened parameters were found. The lowest resting metabolic rate (RMR/kg LBM 55.4; 62.6 kJ/kg) was found in brothers (both C, Trp64/Trp64) who highly differ in body constitution (BMI 19.0 resp. 32.4 kg/m2). We suppose that in this case the energy metabolism is probably determined by other genetic loci and does not correlate with body fat mass.
  
  
  CONCLUSIONS
  Our pilot study does not confirm the influence of Trp64Arg mutation in heterozygous carriers on insulin resistance, energy metabolism and lipid spectrum.
authors.affiliation: Endokrinologický ústav, odd. endokrinní biochemie a molekulární genetiky, Praha.
authors.forename: B
authors.initials: B
authors.lastname: Bendlová
authors.forename: I
authors.initials: I
authors.lastname: Mazura
authors.forename: J
authors.initials: J
authors.lastname: Vcelák
authors.forename: T
authors.initials: T
authors.lastname: Pelikánová
authors.forename: M
authors.initials: M
authors.lastname: Kunesová
authors.forename: V
authors.initials: V
authors.lastname: Hainer
authors.forename: J
authors.initials: J
authors.lastname: Obenberger
authors.forename: D
authors.initials: D
authors.lastname: Palyzová
mesh_terms: D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D019943:Amino Acid Substitution; D015992:Body Mass Index; D004734:Energy Metabolism / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007333:Insulin Resistance / Q000235:genetics*; D008055:Lipids / Q000097:blood*; D008297:Male; D024821:Metabolic Syndrome / Q000235:genetics; D009154:Mutation; D022702:Receptors, Adrenergic, beta-3 / Q000235:genetics*
chemical_list: D008055:Lipids; D022702:Receptors, Adrenergic, beta-3